2025-07-22 - Analysis Report
Okay, here's a comprehensive analysis of Natera Inc. (NTRA) based on the provided data, presented in a structured report format.

## Natera Inc. (NTRA) Stock Analysis - July 3, 2025

**Ticker:** NTRA
**Company Name:** Natera Inc.
**Company Overview:**  Natera Inc. is a diagnostics company specializing in cell-free DNA testing for reproductive health, oncology, and organ health.

### 1.  Performance vs. S&P 500 (VOO)

*   **NTRA Cumulative Return:** 117.92%
*   **VOO Cumulative Return:** 97.37%
*   **Absolute Spread:** 20.20% (NTRA outperforming VOO)
*   **Spread Range (Max: 631.9, Min: -39.3):**
*   **Relative Spread:** 8.9

**Analysis:**  NTRA has outperformed the S&P 500 (VOO) with a cumulative return difference of 20.20%. However, the relative spread indicates that the current outperformance is positioned in the lower end compared to historical fluctuations.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta  | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2015-2017  | -6.0%    | 62.4%    | -31.0%  | 0.0   | 1.2    |
| 2016-2018  | 29.0%    | 80.1%    | 11.0%   | 0.0   | 1.9    |
| 2017-2019  | 159.0%   | 80.1%    | 130.0%  | 1.2   | 4.6    |
| 2018-2020  | 530.0%   | 80.1%    | 510.0%  | 0.3   | 13.6   |
| 2019-2021  | 355.0%   | 62.9%    | 307.0%  | 0.2   | 12.8   |
| 2020-2022  | -119.0%  | 62.9%    | -121.0% | 0.2   | 5.5    |
| 2021-2023  | -482.0%  | 69.9%    | -500.0% | 1.1   | 8.6    |
| 2022-2024  | -75.0%   | 70.6%    | -100.0% | 1.2   | 21.6   |
| 2023-2025  | 67.0%    | 74.9%    | 18.0%   | 0.8   | 19.2   |

**Analysis:**

*   **CAGR:**  Shows highly variable growth rates, ranging from significant losses to substantial gains across different periods.
*   **MDD:**  Maximum Drawdown values are consistently high, indicating significant risk and volatility.
*   **Alpha:** Alpha values are generally very high or very low, suggesting a strong capacity for both significant outperformance and underperformance relative to the benchmark.
*   **Beta:** Beta values are low, which suggests that the stock is not moving with the market.
*   **Cap(B):** The market capitalization of the company has changed over the years.

### 2.  Recent Price Action

*   **Last Price:** 140.63
*   **Previous Close:** 138.90
*   **Change:** +1.25 (+1.25)
*   **5-Day Moving Average:** 144.23
*   **20-Day Moving Average:** 158.90
*   **60-Day Moving Average:** 158.74

**Analysis:**  The stock price increased slightly in the last trading session. However, the current price is below all three moving averages, suggesting a potential short-term downward trend. The fact that the 5-day moving average is the closest to the current price might indicate a possible stabilization or a slowing of the downtrend, but the 20-day and 60-day MAs above suggest resistance levels.

### 3.  Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3383 (Low Risk)
*   **RSI:** 17.90 (Oversold)
*   **PPO:** -1.81
*   **Hybrid Signal:** Cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Spread Change:** -1.5 (Short-term Decline)
*   **Expected Return:** 190.7% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** The MRI suggests a low-risk market environment.
*   **RSI:** The RSI value of 17.90 indicates that the stock is currently oversold, which might suggest a potential for a price rebound.
*   **PPO:**  The negative PPO value suggests a short-term downward trend.
*   **Hybrid Signal:** The Hybrid Signal recommends reducing holdings and increasing cash position, showing caution despite the low-risk MRI.
*   **Relative Spread Change:** The recent decline in relative spread supports the cautious outlook.
*   **Expected Return:** The high expected return indicates significant potential long-term outperformance, but should be considered in light of the historical volatility.
*   **Price Change Reaction:** The "change" of 1.25 is not significant enough to indicate a major issue but rather a regular fluctuation.

### 4.  Recent News & Significant Events

*   **2025-07-20:** NTRA has recently made headlines due to major business developments, regulatory changes, or market events.
*   **2025-07-18:** Analysts are discussing NTRA's recent performance and its outlook in the context of industry trends and global economic factors.
*   **2025-07-19:** NTRA's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **2025-07-21:** Market experts highlight both risks and opportunities for NTRA, advising investors to monitor recent news and company announcements.

**Analysis:**  Recent news suggests increased scrutiny and volatility surrounding NTRA, likely influenced by business developments, regulatory changes, and broader economic factors. Monitoring news and company announcements is crucial.

### 5.  Recent Earnings Analysis

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-05-09 | -0.50 | 0.50 B$    |
| 2024-11-12 | -0.26 | 0.44 B$    |
| 2024-08-09 | -0.30 | 0.41 B$    |
| 2024-05-10 | -0.56 | 0.37 B$    |
| 2025-05-09 | -0.56 | 0.37 B$    |

**Analysis:**

*   **EPS:**  The company has consistently reported negative earnings per share (EPS) over the observed period.
*   **Revenue:** Revenue has generally been increasing, but EPS has not improved accordingly, indicating potential challenges in controlling costs or improving profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.50B  | 63.12%        |
| 2024-12-31 | $0.48B  | 62.94%        |
| 2024-09-30 | $0.44B  | 61.79%        |
| 2024-06-30 | $0.41B  | 58.83%        |
| 2024-03-31 | $0.37B  | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-03-31 | $1.24B    | -5.40%  |
| 2024-12-31 | $1.20B    | -4.50%  |
| 2024-09-30 | $0.88B    | -3.60%  |
| 2024-06-30 | $0.84B    | -4.48%  |
| 2024-03-31 | $0.79B    | -8.51%  |

**Analysis:**

*   **Revenue:** Revenue has been growing steadily over the past year.
*   **Profit Margin:** Profit margins are relatively high and have been increasing, which is a positive sign.
*   **Equity:** Equity has increased significantly, reflecting overall growth and investment.
*   **ROE:** Return on Equity (ROE) is negative, consistent with the negative EPS, but appears to be improving (less negative) in recent quarters.

### 7.  Overall Analysis and Recommendation

**Summary:**

Natera Inc. (NTRA) presents a mixed investment picture. While it has outperformed the S&P 500 and shows strong revenue growth and high profit margins, it also exhibits high volatility, negative earnings, and a recent decline in short-term price momentum. The high expected return suggests long-term potential, but this must be balanced against the inherent risks.

**Recommendation:**

*   **Caution Advised:**  Given the negative earnings, high volatility, and recent negative trends, a cautious approach is warranted.
*   **Monitor News:** Closely monitor news and company announcements to stay informed about business developments, regulatory changes, and potential impacts on the stock price.
*   **Consider Small Position (if bullish):** If you are bullish on the long-term prospects of Natera and its industry, consider initiating a small position, with a focus on long-term growth rather than short-term gains.
*   **Heed Hybrid Signal:** The Hybrid Signal's recommendation to increase cash position should be taken seriously, as it reflects caution in the current market conditions.
*   **Potential Rebound:** The oversold RSI level suggests a potential for a short-term rebound, but this should not be the sole basis for investment decisions.
